Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17.3M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
8.4M
-
Shares change
-
-813K
-
Total reported value, excl. options
-
$10.6M
-
Value change
-
-$2.68M
-
Put/Call ratio
-
0.03
-
Number of buys
-
21
-
Number of sells
-
-37
-
Price
-
$1.26
Significant Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q1 2025
82 filings reported holding MURA - Mural Oncology plc - Ordinary shares, nominal value $0.01 per share as of Q1 2025.
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.4M shares
of 17.3M outstanding shares and own 48.65% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.72M shares), ACORN CAPITAL ADVISORS, LLC (1.27M shares), Solas Capital Management, LLC (888K shares), VANGUARD GROUP INC (784K shares), Newtyn Management, LLC (570K shares), Prosight Management, LP (423K shares), BlackRock, Inc. (343K shares), RBF Capital, LLC (316K shares), Verition Fund Management LLC (185K shares), and GEODE CAPITAL MANAGEMENT, LLC (183K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.